852 852 Pill - gray capsule/oblong, 16mm
Pill with imprint 852 852 is Gray, Capsule/Oblong and has been identified as Minocycline Hydrochloride 75 mg. It is supplied by Caraco Pharmaceutical Laboratories, Ltd.
Minocycline is used in the treatment of Bacterial Infection; Acne; Bartonellosis; Bullous Pemphigoid; Actinomycosis and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 75 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 852 852
Minocycline Hydrochloride
- Imprint
- 852 852
- Strength
- 75 mg
- Color
- Gray
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Caraco Pharmaceutical Laboratories, Ltd.
- National Drug Code (NDC)
- 57664-0852
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
povidone,
sodium starch glycolate type A potato,
magnesium stearate,
gelatin,
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Blue No. 2,
FD&C Red No. 40,
ferrosoferric oxide,
shellac,
silicon dioxide,
titanium dioxide,
propylene glycol
Note: Inactive ingredients may vary.
Related images for "852 852"
More about minocycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (564)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: tetracyclines
- Breastfeeding
- En español
Patient resources
- Minocycline drug information
- Minocycline (Intravenous) (Advanced Reading)
- Minocycline Capsules and Tablets
- Minocycline Extended-Release Tablets
Other brands
Minocin, Emrosi, Dynacin, Ximino, ... +3 more
Professional resources
- Minocycline monograph
- Minocycline (EENT) (AHFS Monograph)
- Minocycline (FDA)
- Minocycline Capsules (FDA)
- Minocycline Extended Release Tablets (FDA)
Other brands
Minocin, Emrosi, Ximino, Minocin for Injection, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.